Form 4: MapLight Therapeutics Executive Sells Shares
Insider Transaction (Form 4)
James Woodruff Lillie, Chief Scientific Officer of MapLight Therapeutics, Inc., sold 22,082 shares of common stock on August 3, 2026 for $12.54 per share.
Summary
- Open-market sale: disposed of 22,082 Voting Common Stock at $12.54 ($276,908) on August 3, 2026; holds 202,380 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $276,908 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
James Woodruff Lillie — Officer (Chief Scientific Officer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-03 | Open-market sale | Voting Common Stock | 22,082 | $13 | $276.9K | 202,380 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-03 | Open-market sale (22,082 shares) |
Keywords
insider transaction, Form 4, MPLT, MapLight Therapeutics, Inc., bearish, James Woodruff Lillie
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.